Category Archives: Pr Newswire

International Youth Day 2024: Shanghai Electric Launches Onboarding Training for New Recruits with Focus on Youth Career Development

Over 700 graduates joined Shanghai Electric in the latest wave of hiring, together with the company to turn ideas into innovation that helps accelerate the smart and green transformation of the energy industry SHANGHAI, Aug. 13, 2024 /PRNewswire/ — Shanghai Electric (SEHK: 2727, SSE: 601727) recently launched a comprehensive training program tailored for over 700 newly recruited […]

HUYA Inc. Reports Second Quarter 2024 Unaudited Financial Results and Announces Share Repurchase Program Extension and Special Cash Dividend

GUANGZHOU, China, Aug. 13, 2024 /PRNewswire/ — HUYA Inc. (“Huya” or the “Company”) (NYSE: HUYA), a leading game live streaming platform in China, today announced its unaudited financial results for the second quarter ended June 30, 2024. Second Quarter 2024 Highlights[1] Total net revenues for the second quarter of 2024 were RMB1,541.6 million (US$212.1 million), compared with […]

X Financial to Report Second Quarter 2024 Financial Results on August 22, 2024

SHENZHEN, China, Aug. 13, 2024 /PRNewswire/ — X Financial (NYSE: XYF) (the “Company”), a leading online personal finance company in China, today announced that it will release its unaudited financial results for the second quarter ended June 30, 2024, before the open of U.S. markets on Thursday, August 22, 2024. X Financial’s management team will […]

Brand Builder Thomas Pigeon Joins Leading International Regenerative Medicine and Longevity Company Eterna Health as CMO

Thomas Pigeon Appointed as CMO of Eterna Health, Enhancing the Brand’s Reach in Regenerative Medicine MISSISSAUGA , Ontario, Aug. 12, 2024 (GLOBE NEWSWIRE) — Dr. Adeel Khan, CEO and Founder of Eterna Health today announces the appointment of Thomas Pigeon as Chief Marketing Officer “Our growth curve has been rapid and exciting. As we evolve […]

Dyne Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

– Recent Data from ACHIEVE Trial of DYNE-101 in DM1 and DELIVER Trial of DYNE-251 in DMD Demonstrated Compelling Impact on Key Disease Biomarkers and Improvement in Multiple Functional Endpoints – – Strengthened Balance Sheet with $374 Million Public Offering Extending Projected Cash Runway At Least Into the Second Half of 2026 – WALTHAM, Mass., […]

Extendicare Announces 2024 Second Quarter Results

MARKHAM, Ontario, Aug. 12, 2024 (GLOBE NEWSWIRE) — Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three and six months ended June 30, 2024. Second Quarter 2024 Highlights Adjusted EBITDA(1) excluding out-of-period items improved by $19.7 million to $34.5 million, largely driven by rate increases in long-term care (“LTC”) and […]

Orchestra BioMed Reports Second Quarter 2024 Financial Results and Provides a Business Update

NEW HOPE, Pa., Aug. 12, 2024 (GLOBE NEWSWIRE) — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today reported its second quarter 2024 financial results and provided a business update. “Our work in hypertension and coronary artery disease aligns […]

Sanara MedTech Inc. Announces Second Quarter 2024 Results

FORT WORTH, TX, Aug. 12, 2024 (GLOBE NEWSWIRE) — Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare […]

Celltrion USA announces incorporation of adalimumab-aaty, a Humira® biosimilar, to the Costco Member Prescription Program

Adalimumab-aaty was first approved by the Food and Drug Administration on May 23, 2023 and became commercially available among key distributors across the U.S. on July 2, 2023 Adalimumab-aaty’s inclusion creates greater accessibility to treatments for Americans with inflammatory conditions JERSEY CITY, N.J., Aug. 13, 2024 /PRNewswire/ — Celltrion USA, Inc., (Celltrion USA) today announced […]

Toss Securities Achieves Full-Year Profit Target in H1 2024, Led by Strong Performance in U.S. Securities Trading

Toss Securities logs exceptional financial performance, achieving full-year target in just six months Strong performance in U.S. securities trading was instrumental in driving growth Building on quarterly profit in Q1, Toss Securities’ strong Q2 results highlight consistent profitability SEOUL, South Korea, Aug. 13, 2024 /PRNewswire/ — Toss Securities has reported a strong performance in the […]